采用3-T MRI对阿尔茨海默病脑铁水平的横断面与纵向评估
该前瞻性研究纳入100例阿尔茨海默病患者与100例年龄匹配的健康对照,采用3-T MRI R2* mapping评估脑铁水平,发现患者基底节和总新皮质及枕叶、颞叶R2*值更高,且颞叶R2*纵向变化与认知下降相关。
要点
- AD患者基底节R2*中位数30.2 sec⁻¹高于健康对照29.0 sec⁻¹(P=.01)。
- AD患者总新皮质R2*中位数17.4 sec⁻¹高于健康对照17.0 sec⁻¹(P<.001)。
- AD患者颞叶R2*纵向变化与CERAD总分变化相关(β=-3.23 score/sec⁻¹,P=.003)。
核心结论
- 阿尔茨海默病患者深部灰质和新皮质区域铁浓度高于健康对照。
- 颞叶铁水平随时间的变化与阿尔茨海默病患者的认知下降相关。
研究设计与样本
- 前瞻性研究,纳入2010至2016年招募的100例阿尔茨海默病患者和2010至2014年选取的100例年龄匹配健康对照。
- 100例患者中56例在平均17个月随访时接受后续神经心理学测试和脑MRI。
- 所有参与者接受3-T MRI,包括经宏观B0场不均匀性校正的R2* mapping。
- 分割解剖结构并计算新皮质、皮质脑叶、基底节、海马和丘脑的R2*中位数。
- 采用多变量线性回归分析组间R2*差异及AD组R2*纵向变化与认知的关联。
关键影像表现/征象
- AD组基底节R2*中位数30.2 sec⁻¹高于健康对照29.0 sec⁻¹(P=.01)。
- AD组总新皮质R2*中位数17.4 sec⁻¹高于健康对照17.0 sec⁻¹(P<.001)。
- AD组枕叶R2*中位数20.2 sec⁻¹高于健康对照19.6 sec⁻¹(P=.007)。
- AD组颞叶R2*中位数18.1 sec⁻¹高于健康对照16.4 sec⁻¹(P<.001)。
诊断标准与关键数值
- AD组基底节R2*中位数30.2 sec⁻¹ vs 健康对照29.0 sec⁻¹(P=.01)。
- AD组总新皮质R2*中位数17.4 sec⁻¹ vs 健康对照17.0 sec⁻¹(P<.001)。
- AD组枕叶R2*中位数20.2 sec⁻¹ vs 健康对照19.6 sec⁻¹(P=.007)。
- AD组颞叶R2*中位数18.1 sec⁻¹ vs 健康对照16.4 sec⁻¹(P<.001)。
- AD组颞叶R2*值与CERAD总分纵向变化相关(β=-3.23 score/sec⁻¹,P=.003),独立于脑体积纵向变化。
临床应用与阅片要点
- 3-T MRI R2* mapping可用于评估阿尔茨海默病患者深部灰质和新皮质脑铁水平。
- 颞叶R2*值纵向变化与认知下降相关,或可作为影像学随访指标。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Background Deep gray matter structures in patients with Alzheimer disease (AD) contain higher brain iron concentrations. However, few studies have included neocortical areas, which are challenging to assess with MRI. Purpose To investigate baseline and change in brain iron levels using MRI at 3 T with R2* relaxation rate mapping in individuals with AD compared with healthy control (HC) participants. Materials and Methods In this prospective study, participants with AD recruited between 2010 and 2016 and age-matched HC participants selected from 2010 to 2014 were evaluated. Of 100 participants with AD, 56 underwent subsequent neuropsychological testing and brain MRI at a mean follow-up of 17 months. All participants underwent 3-T MRI, including R2* mapping corrected for macroscopic B0 field inhomogeneities. Anatomic structures were segmented, and median R2* values were calculated in the neocortex and cortical lobes, basal ganglia (BG), hippocampi, and thalami. Multivariable linear regression analysis was applied to study the difference in R2* levels between groups and the association between longitudinal changes in R2* values and cognition in the AD group. Results A total of 100 participants with AD (mean age, 73 years ± 9 [standard deviation]; 58 women) and 100 age-matched HC participants (mean age, 73 years ± 9; 60 women) were evaluated. Median R2* levels were higher in the AD group than in the HC group in the BG (HC, 29.0 sec-1; AD, 30.2 sec-1; P = .01) and total neocortex (HC, 17.0 sec-1; AD, 17.4 sec-1; P < .001) and regionally in the occipital (HC, 19.6 sec-1; AD, 20.2 sec-1; P = .007) and temporal (HC, 16.4 sec-1; AD, 18.1 sec-1; P < .001) lobes. R2* values in the temporal lobe were associated with longitudinal changes in Consortium to Establish a Registry for Alzheimer's Disease total score (β = -3.23 score/sec-1, P = .003) in participants with AD independent of longitudinal changes in brain volume. Conclusion Iron concentration in the deep gray matter and neocortical regions was higher in patients with Alzheimer disease than in healthy control participants. Change in iron levels over time in the temporal lobe was associated with cognitive decline in individuals with Alzheimer disease. © RSNA, 2020 Online supplemental material is available for this article.
引用
- Damulina A, Pirpamer L, Soellradl M, et al. Cross-sectional and Longitudinal Assessment of Brain Iron Level in Alzheimer Disease Using 3-T MRI. Radiology. 2020. PMID: 32602825. doi:10.1148/radiol.2020192541
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。